Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

502
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
502
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

293
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
293
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

461
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
461
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

653
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
653

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Relationship between continuous infusion meropenem PK/PD target attainment and C-reactive protein dynamics in onco-haematologic patients with febrile neutropenia.

British journal of clinical pharmacology·2026
Same author

Strain-dependent variability in pharmacodynamic interactions for phage-antibiotic combinations in Pseudomonas aeruginosa.

International journal of antimicrobial agents·2026
Same author

Copulas for Covariate Simulation in Pharmacometrics.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Assessing the impact of bacterial heterogeneity on bacteriophage population dynamics.

Journal of pharmacokinetics and pharmacodynamics·2026
Same author

Clinical prevalence of collateral sensitivity: a systematic exploration of multicentre antimicrobial surveillance data.

The Lancet. Microbe·2026
Same author

Topological Investigation of Protein Folding and Intrinsic Disorder.

The journal of physical chemistry. B·2026

相关实验视频

Updated: Jan 9, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.2K

聚合数据建模:快速实现将药理学模型与R中的总结级数据相匹配.

Hidde van de Beek1, Pyry A J Välitalo2,3, J G Coen van Hasselt4

  • 1Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands. h.van.de.beek@lacdr.leidenuniv.nl.

Journal of pharmacokinetics and pharmacodynamics
|December 9, 2025
PubMed
概括
此摘要是机器生成的。

药量计建模现在使用新的admr R包整合了聚合数据. 一个新的代重权蒙特卡洛 (IR-MC) 算法显著加快复杂模型估计.

关键词:
汇总数据汇总数据.基于模型的元分析.制药指标 (Pharmacometrics) 是一个指标.人口的药理动力学.在R包中,R包是R包.

更多相关视频

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.7K
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

826

相关实验视频

Last Updated: Jan 9, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.2K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.7K
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

826

科学领域:

  • 制药指标 (Pharmacometrics) 是一个指标.
  • 计算生物学 计算生物学
  • 统计建模 统计建模

背景情况:

  • 传统的药量计模型依赖于个人级别的数据.
  • 一种新方法使得配合药量计模型能够汇总数据,允许对多种数据源进行联合分析.
  • 这种方法可以结合个人数据,药量测量模型和聚合数据.

研究的目的:

  • 在一个可访问的R包 (admr) 中实现聚合数据建模框架.
  • 开发一种新的算法 (Iterative Reweighting Monte Carlo - IR-MC) 以提高聚合数据建模中的计算效率.

主要方法:

  • 开发admr R套件,用于计算汇总数据,合并数据源,评估模型性能.
  • 实施IR-MC算法,通过反复加权蒙特卡洛预测来提高计算效率.
  • 通过三个模拟场景和不同的数据生成模型测试算法.

主要成果:

  • 该admr R包提供了一个用户友好的界面,用于聚合数据建模.
  • 与标准蒙特卡洛方法相比,IR-MC算法实现了3到100倍的加速度.
  • 计算效率的提高随着模型复杂度的增加而增加,证明了先进的药量计模型的实用性.

结论:

  • 该admr R包提供了一个快速和可访问的总数据建模框架的实现.
  • IR-MC算法提高了药量计建模的计算效率,特别是复杂的模型.
  • 这种方法方便在药量分析中整合各种数据源.